C-terminus of the B-chain of relaxin-3 is important for receptor activity

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Shabanpoor, Fazel ^a   Bathgate, Ross A D ^a,b   Wade, John D ^a,b   Hossain, Mohammed Akhter ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CARBOXYL GROUP; PEPTIDE; RECEPTOR; RELAXIN 3; RXFP3 RECEPTOR; RXFP4 RECEPTOR; UNCLASSIFIED DRUG;

AMIDATION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; CYCLIC AMP; HUMANS; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN;

EID: 84892407550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082567     Document Type: Article

References (41)

1. Bathgate RA, Samuel CS, Burazin TC, Layfield S, Claasz AA, et al. (2002) Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem 277: 1148-1157.
2. Wilkinson TN, Speed TP, Tregear GW, Bathgate RA (2005) Evolution of the relaxin-like peptide family. BMC Evol Biol 5: 14.
3. Shabanpoor F, Separovic F, Wade JD (2009) The human insulin superfamily of polypeptide hormones. Vitam Horm 80: 1-31.
4. Rosengren KJ, Lin F, Bathgate RA, Tregear GW, Daly NL, et al. (2006) Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3. J Biol Chem 281: 5845-5851.
5. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ (2006) International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58: 7-31.
6. Liu C, Eriste E, Sutton S, Chen J, Roland B, et al. (2003) Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278: 50754-50764.
7. Bathgate RA, Lin F, Hanson NF, Otvos L, Jr., Guidolin A, et al. (2006) Relaxin- 3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 45: 1043-1053.
8. Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, et al. (2010) Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol 518: 4016-4045.
9. Ma S, Sang Q, Lanciego JL, Gundlach AL (2009) Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate. J Comp Neurol 517: 856-872.
10. Smith CM, Ryan PJ, Hosken IT, Ma S, Gundlach AL (2011) Relaxin-3 systems in the brain - the first 10 years. J Chem Neuroanat 42: 262-275.
11. Sutton SW, Bonaventure P, Kuei C, Roland B, Chen J, et al. (2004) Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 80: 298-307.
12. Banerjee A, Shen PJ, Ma S, Bathgate RA, Gundlach AL (2010) Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 58: 145-155.
13. Ma S, Olucha-Bordonau FE, Hossain MA, Lin F, Kuei C, et al. (2009) Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn Mem 16: 730-742.
14. McGowan BM, Stanley SA, Smith KL, Minnion JS, Donovan J, et al. (2006) Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept 136: 72-77.
15. Hida T, Takahashi E, Shikata K, Hirohashi T, Sawai T, et al. (2006) Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res 26: 147-158.
16. Hossain MA, Rosengren KJ, Haugaard-Jonsson LM, Zhang S, Layfield S, et al. (2008) The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. J Biol Chem 283: 17287-17297.
17. Shabanpoor F, Bathgate RA, Belgi A, Chan LJ, Nair VB, et al. (2012) Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone. Biochem Biophys Res Commun 420: 253-256.
18. Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, et al. (2007) R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. J Biol Chem 282: 25425-25435.
19. Katayama H, Ohira T, Aida K, Nagasawa H (2002) Significance of a carboxyl-terminal amide moiety in the folding and biological activity of crustacean hyperglycemic hormone. Peptides 23: 1537-1546.
20. Haugaard-Kedstrom LM, Shabanpoor F, Hossain MA, Clark RJ, Ryan PJ, et al. (2011) Design, Synthesis, and Characterization of a Single-Chain Peptide Antagonist for the Relaxin-3 Receptor RXFP3. J Am Chem Soc 133: 4965-4974.
21. Alvarez-Jaimes L, Sutton SW, Nepomuceno D, Motley ST, Cik M, et al. (2012) In vitro pharmacological characterization of RXFP3 allosterism: an example of probe dependency. PLoS One 7: e30792.
22. Maruyama K, Nagata K, Tanaka M, Nagasawa H, Isogai A, et al. (1992) Synthesis of bombyxin-IV, an insulin superfamily peptide from the silkworm, Bombyx mori, by stepwise and selective formation of three disulfide bridges. J Protein Chem 11: 1-12.
23. Shabanpoor F, Akhter Hossain M, Ryan PJ, Belgi A, Layfield S, et al. (2012) Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1. J Med Chem 55: 1671-1681.
24. Shabanpoor F, Hughes RA, Bathgate RA, Zhang S, Scanlon DB, et al. (2008) Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions. Bioconjug Chem 19: 1456-1463.
25. Shabanpoor F, Hughes RA, Zhang S, Bathgate RA, Layfield S, et al. (2010) Effect of helix-promoting strategies on the biological activity of novel analogues of the B-chain of INSL3. Amino Acids 38: 121-131.
26. Scholtz JM, Qian H, York EJ, Stewart JM, Baldwin RL (1991) Parameters of helix-coil transition theory for alanine-based peptides of varying chain lengths in water. Biopolymers 31: 1463-1470.
27. Shabanpoor F, Separovic F, Wade JD (2011) General method for selective labelling of double-chain cysteine-rich peptides with a lanthanide chelate via solid-phase synthesis. J Pept Sci 17: 169-173.
28. Samuel CS, Lin F, Hossain MA, Zhao C, Ferraro T, et al. (2007) Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin. Biochemistry 46: 5374-5381.
29. Hossain MA, Belgi A, Lin F, Zhang S, Shabanpoor F, et al. (2009) Use of a temporary "solubilizing" peptide tag for the Fmoc solid-phase synthesis of human insulin glargine via use of regioselective disulfide bond formation. Bioconjug Chem 20: 1390-1396.
30. Hossain MA, Zhang S, Lin F, Ferraro T, Bathgate RAD, et al. (2006) Regioselective Disulfide Solid Phase Synthesis, Chemical Characterization and In Vitro Receptor Binding Activity of Equine Relaxin. Int J Peptide Res Therap 12: 211-215.
31. Belgi A, Hossain MA, Shabanpoor F, Chan L, Zhang S, et al. (2011) Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation. Biochemistry 50: 8352-8361.
32. Mosco A, Edomi P, Guarnaccia C, Lorenzon S, Pongor S, et al. (2008) Functional aspects of cHH C-terminal amidation in crayfish species. Regul Pept 147: 88-95.
33. Sandvik AK, Dockray GJ (1999) Biological activity of carboxy-terminal gastrin analogs. Eur J Pharmacol 364: 199-203.
34. Dennison SR, Phoenix DA (2011) Influence of C-terminal amidation on the efficacy of modelin-5. Biochemistry 50: 1514-1523.
35. Wang CL, Yao JL, Yu Y, Shao X, Cui Y, et al. (2008) Structure-activity study of endomorphin-2 analogs with C-terminal modifications by NMR spectroscopy and molecular modeling. Bioorg Med Chem 16: 6415-6422.
36. Krstenansky JL, Payne MH, Owen TJ, Yates MT, Mao SJ (1989) C-terminal peptide alcohol, acid and amide analogs of desulfato hirudin54-65 as antithrombin agents. Thromb Res 54: 319-325.
37. Aumelas A, Sakarellos C, Lintner K, Fermandjian S, Khosla MC, et al. (1985) Studies on angiotensin II and analogs: impact of substitution in position 8 on conformation and activity. Proc Natl Acad Sci U S A 82: 1881-1885.
38. Hossain MA, Rosengren KJ, Samuel CS, Shabanpoor F, Chan LJ, et al. (2011) The minimal active structure of human relaxin-2. J Biol Chem 286: 37555-37565.
39. Bullesbach EE, Schwabe C (2012) Replacement of disulfides by amide bonds in the relaxin-like factor (RLF/INSL3) reveals a role for the A11-B10 link in transmembrane signaling. Biochemistry 51: 4198-4205.
40. Thomas KA, Smith GM, Thomas TB, Feldmann RJ (1982) Electronic distributions within protein phenylalanine aromatic rings are reflected by the three-dimensional oxygen atom environments. Proc Natl Acad Sci U S A 79: 4843-4847.
41. Bathgate RA, Oh MH, Ling WJ, Kaas Q, Hossain MA, et al. (2013) Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3. Front Endocrinol (Lausanne) 4: 13.